Table 1 Perioperative data (Varese, 2014)
Surgeon A | Surgeon B | |
|---|---|---|
Cases (n) | 48 | 52 |
Median age (yrs, range) | 71 (50–86) | 68 (51–84) |
Median Adenoma volume (TRUS, ml, range) | 61 (30–130) | 60 (30–105) |
Median PSA (ng/dl, range) | 6.32 (1.2–37.1) | 5.98 (0.7–23.6) |
I-PSS moderate/high | 24/ 17 (7 n.v.) | 25/ 17 (10 n.v.) |
Median Surgical time (min, range) | 92 (34–160) | 86 (40–127) |
Median Laser emission time (min, range) | 28 (16–58,44) | 24 (19–37,16) |
Median Total energy delivered (J, range) | 165,650 (84,820–386,920) | 163,445 (87,540–358,327) |
600 μm fiber use (no. cases) | 18 | 11 |
800 μm fiber use (no. cases) | 30 | 41 |
Intraoperative complications | •1 Bladder perforation | •1 Bladder perforation |
•1 Intraoperative bleeding, with necessity to delay morcellation | ||
Contemporary procedures | •3 bladder ELT | •2 URS |
•5 bladder ELT | ||
Reoperations | •1 Morcellation on first postoperative day | •1 Hemostatic TUR (first postoperative day) |
•1 TURP for chronic retention (6 months later) | •1 Morcellation of a residual fragment (1 month later) | |
•1 Urethrotomy for bulbar urethral stenosis (9 months later) |